954 Clinical results from a phase I dose escalation study in treatment-naïve early stage prostate cancer patients with ORCA-010, a potency enhanced oncolytic replication competent adenovirus
| Published in: | Journal for ImmunoTherapy of Cancer |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Article in Journal/Newspaper |
| Language: | English |
| Published: |
BMJ Publishing Group
2021
|
| Subjects: | |
| Online Access: | https://doi.org/10.1136/jitc-2021-SITC2021.954 https://doaj.org/article/2c4cd2b93c724d0e9682c4265c27a61a |
| _version_ | 1821677295838953472 |
|---|---|
| author | Richard Casey Wenliang Dong Tereza Brachtlova Allan Abramovitch Jonathan Giddens Peter Incze Kenneth Jansz Victor van Beusechem |
| author_facet | Richard Casey Wenliang Dong Tereza Brachtlova Allan Abramovitch Jonathan Giddens Peter Incze Kenneth Jansz Victor van Beusechem |
| author_sort | Richard Casey |
| collection | Directory of Open Access Journals: DOAJ Articles |
| container_issue | Suppl 2 |
| container_start_page | A1004 |
| container_title | Journal for ImmunoTherapy of Cancer |
| container_volume | 9 |
| format | Article in Journal/Newspaper |
| genre | Orca |
| genre_facet | Orca |
| id | ftdoajarticles:oai:doaj.org/article:2c4cd2b93c724d0e9682c4265c27a61a |
| institution | Open Polar |
| language | English |
| op_collection_id | ftdoajarticles |
| op_container_end_page | A1004 |
| op_doi | https://doi.org/10.1136/jitc-2021-SITC2021.954 |
| op_relation | https://doaj.org/toc/2051-1426 doi:10.1136/jitc-2021-SITC2021.954 2051-1426 https://doaj.org/article/2c4cd2b93c724d0e9682c4265c27a61a |
| op_source | Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021) |
| publishDate | 2021 |
| publisher | BMJ Publishing Group |
| record_format | openpolar |
| spelling | ftdoajarticles:oai:doaj.org/article:2c4cd2b93c724d0e9682c4265c27a61a 2025-01-17T00:09:22+00:00 954 Clinical results from a phase I dose escalation study in treatment-naïve early stage prostate cancer patients with ORCA-010, a potency enhanced oncolytic replication competent adenovirus Richard Casey Wenliang Dong Tereza Brachtlova Allan Abramovitch Jonathan Giddens Peter Incze Kenneth Jansz Victor van Beusechem 2021-11-01T00:00:00Z https://doi.org/10.1136/jitc-2021-SITC2021.954 https://doaj.org/article/2c4cd2b93c724d0e9682c4265c27a61a EN eng BMJ Publishing Group https://doaj.org/toc/2051-1426 doi:10.1136/jitc-2021-SITC2021.954 2051-1426 https://doaj.org/article/2c4cd2b93c724d0e9682c4265c27a61a Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021) Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 article 2021 ftdoajarticles https://doi.org/10.1136/jitc-2021-SITC2021.954 2022-12-31T15:37:04Z Article in Journal/Newspaper Orca Directory of Open Access Journals: DOAJ Articles Journal for ImmunoTherapy of Cancer 9 Suppl 2 A1004 A1004 |
| spellingShingle | Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Richard Casey Wenliang Dong Tereza Brachtlova Allan Abramovitch Jonathan Giddens Peter Incze Kenneth Jansz Victor van Beusechem 954 Clinical results from a phase I dose escalation study in treatment-naïve early stage prostate cancer patients with ORCA-010, a potency enhanced oncolytic replication competent adenovirus |
| title | 954 Clinical results from a phase I dose escalation study in treatment-naïve early stage prostate cancer patients with ORCA-010, a potency enhanced oncolytic replication competent adenovirus |
| title_full | 954 Clinical results from a phase I dose escalation study in treatment-naïve early stage prostate cancer patients with ORCA-010, a potency enhanced oncolytic replication competent adenovirus |
| title_fullStr | 954 Clinical results from a phase I dose escalation study in treatment-naïve early stage prostate cancer patients with ORCA-010, a potency enhanced oncolytic replication competent adenovirus |
| title_full_unstemmed | 954 Clinical results from a phase I dose escalation study in treatment-naïve early stage prostate cancer patients with ORCA-010, a potency enhanced oncolytic replication competent adenovirus |
| title_short | 954 Clinical results from a phase I dose escalation study in treatment-naïve early stage prostate cancer patients with ORCA-010, a potency enhanced oncolytic replication competent adenovirus |
| title_sort | 954 clinical results from a phase i dose escalation study in treatment-naïve early stage prostate cancer patients with orca-010, a potency enhanced oncolytic replication competent adenovirus |
| topic | Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
| topic_facet | Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
| url | https://doi.org/10.1136/jitc-2021-SITC2021.954 https://doaj.org/article/2c4cd2b93c724d0e9682c4265c27a61a |